编号：2016-01 证券代码：000516 证券简称：国际医学 西安国际医学投资股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|----------------------------------|----------------------------------------------------------| | | | | | | √ 特定对象调研 | □ 分析师会议 | | | □ 媒体采访 | □ 业绩说明会 | | 投资者关系活动 | □ 新闻发布会 | □ 路演活动 | | 类别 | □ 现场参观 | | | | □ 其他 _________ | | | 参与单位名称及 | 安信证券 吴晓楠；中融信托 赵晓媛 | | | 人员姓名 | | | | 时间 | 2016 年 05 月 24 | 日 | | 地点 | 国际医学会议室 | | | | | | | 上市公司接待人 员姓名 | | 董事会秘书：管港先生 证券事务代表：杜睿男先生 | | 投资者关系活动 | | 主要了解公司经营管理的简要情况，具体问题如下： | ...

编号：2016-03 证券代码：000516 证券简称：国际医学 西安国际医学投资股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|--------------------------|----------------------------------------------------------| | | | | | | √ 特定对象调研 | □ 分析师会议 | | | □ 媒体采访 | □ 业绩说明会 | | 投资者关系活动 | □ 新闻发布会 | □ 路演活动 | | 类别 | □ 现场参观 | | | | □ 其他 _________ | | | 参与单位名称及 | 财达证券 平敬伟 | | | 人员姓名 | | | | 时间 | 2016 年 09 月 22 | 日 | | 地点 | 国际医学会议室 | | | 上市公司接待人 | | | | 员姓名 | 证券事务代表：杜睿男先生 | | | 投资者关系活动 | | 主要了解公司经营管理的简要情况，具体问题如下： | | 主要内容介绍 | 1 | 、公司医疗服务业务未来的规划？ | | ...

证券代码：000516 证券简称：国际医学 西安国际医学投资股份有限公司投资者关系活动记录表 编号：2020-05 1 | --- | --- | --- | --- | |----------------|-----------|---------------------------------------------|--------------------------| | | | √特定对象调研 √分析师会议 | | | | | □媒体采访 □业绩说明会 | | | 投资者关系活动 | □ | 新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | | □ 其他 | | | | 参与单位名称及 | | 1、分析师会议： | | | 人员姓名 | 1 | Artisan Partners Asset Management Inc | Gu, Chen | | | 2 | China Asset Management | Zhang, Jun | | | 3 | China Re Asset Mgmt (Hong Kong) Co Ltd | Li, Junzhou | | | | | ...

编号：2020-09 1 证券代码：000516 证券简称：国际医学 西安国际医学投资股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|------------------------------------|--------------------------------------------------------| | | | | | | | □特定对象调研 √分析师会议 | | | □媒体采访 □业绩说明会 | | | 投资者关系活动 | □ | 新闻发布会 □路演活动 | | 类别 | □现场参观 | | | | □ 其他 | | | 参与单位名称及 | | 信达证券周贤珮，源乐晟欧阳明、马韵羽、卢奕璇。 | | 人员姓名 | | | | 时间 地点 | 2020 年 7 月 28 电话会议 | 日 10:30-11:30 | | | | | | 上市公司接待人 员姓名 | | 副总裁兼董事会秘书丁震、证券事务代表杜睿男 | | 投资者关系活动 | | 主要介绍公司经营发展的简要情况，具体内容如下： | | 主要内容介绍 | ...

证券代码：000516 证券简称：国际医学 编号：2020-01 1 西安国际医学投资股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|------------------------------|----------------------------------------------------------| | | | | | | □ 特定对象调研 | □ 分析师会议 | | | □ 媒体采访 | □ 业绩说明会 | | 投资者关系活动 | □ 新闻发布会 | □ 路演活动 | | 类别 | □ 现场参观 | | | | √ 其他（电话会议交流） | | | 参与单位名称及 | | 兴业证券徐佳熹、东楠，申万宏源证券熊超逸，万家基金王霄 | | 人员姓名 | | 音，中美大都会周晔，中证信用王建强，九泰基金张羽，人保 | | | | 寿险陈维，人保资产吴锋，凯石基金盛夏，北信瑞丰邓文强， | | | | 华商基金孙蔚，华润元大基金廖星昊，博时基金吴文庆，厦门 | | | | 国贸蔡晓川，太平资产袁苇，工银瑞信基金丁洋，平安基金许 | | | ...

编号：2020-08 1 证券代码：000516 证券简称：国际医学 西安国际医学投资股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|-------------------------|--------------------------------------------------------| | | | | | | | √特定对象调研 □分析师会议 | | | | □媒体采访 □业绩说明会 | | 投资者关系活动 | □ | 新闻发布会 □路演活动 | | 类别 | □现场参观 | | | | □ 其他 | | | 参与单位名称及 | | 国元证券刘慧敏、刘巧，东证资管孙梦瑶，博道基金任一林， | | 人员姓名 | | 丹源资产陈晓蕾，财通资管王鑫园，信达资产王晓博。 | | 时间 | 2020 年 7 月 23 | 日 10:30-12:00 | | 地点 | 西安国际医学中心医院 | | | | | | | 上市公司接待人 员姓名 | | 副总裁兼董事会秘书丁震、证券事务代表杜睿男 | | 投资者关系活动 | | 主要介绍 ...

Group 1: Company Overview - The company focuses on health care services and the application of modern medical technology, having been listed on the Shenzhen Stock Exchange since August 9, 1993, making it the first listed company in Shaanxi Province and Northwest China [2][3] - In 2018, the company sold its wholly-owned subsidiary, Kaiyuan Commercial Co., Ltd., to Yintai Department Store Co., Ltd., successfully transforming its business strategy to focus on medical services [3] - The company operates several medical institutions, including Xi'an Gaoxin Hospital and Xi'an International Medical Center Hospital, with ongoing projects to expand its medical facilities [3][4] Group 2: Core Competencies - The company has established a strong brand advantage, with Xi'an Gaoxin Hospital recognized nationally for its comprehensive services and advanced medical equipment [4][5] - It employs a group management model, ensuring efficient operations across its medical institutions with a well-structured governance and management system [5] - The company has built a talented team of medical professionals, with a significant portion of its staff having experience from top-tier hospitals [5][6] Group 3: Xi'an International Medical Center Hospital - The hospital, which began construction in June 2016, has a total investment of CNY 5.575 billion, covering an area of 307 acres with a maximum capacity of 5,037 beds [6][7] - Since its opening on September 25, 2019, the hospital has seen a rapid increase in outpatient and inpatient volumes, with a peak daily outpatient count of 1,300 and nearly 600 inpatients [6][7] - The hospital has implemented comprehensive insurance coverage, including municipal and provincial medical insurance [6][8] Group 4: Financial Performance - In the third quarter of 2019, the company achieved operating revenue of CNY 584.32 million, a year-on-year increase of 9.23%, with a net profit of CNY 81.15 million, up 4.91% [8] - Xi'an Gaoxin Hospital reported over 930,000 outpatient visits in 2018, a growth of 11.7%, and nearly 40,000 inpatient discharges, an increase of 8.1% [7][8] - The company is expanding its capacity with the second phase of Xi'an Gaoxin Hospital, which will add 1,000 beds, doubling its current capacity [8] Group 5: Future Developments - With the opening of Xi'an International Medical Center Hospital and the upcoming completion of the second phase of Xi'an Gaoxin Hospital, the total bed capacity across the three major medical facilities will increase to 8,337 [9] - The company aims to enhance its medical service network and solidify its position as a leading healthcare provider in Northwest China [9]

Company Overview - The company focuses on health care services and the application of modern medical technology, operating major hospitals in Xi'an, including Xi'an International Medical High-tech Hospital and Xi'an International Medical Center Hospital [4][5] - Established in 1998, the company has developed a unique model for the reform and development of China's comprehensive medical industry [5][6] Key Projects and Developments - The Xi'an International Medical Center Hospital, opened on September 25, 2019, is the largest single hospital built in China, significantly enhancing the company's operational scale and market competitiveness [5][9] - Ongoing projects include the expansion of Xi'an International Medical High-tech Hospital (1,000 beds) and the new Xi'an International Medical Shangluo Hospital (1,800 beds), currently in the final stages of construction [10][12] Core Competencies - **Brand Advantage**: The company operates a tier-three comprehensive hospital, with Xi'an International Medical High-tech Hospital recognized nationally for its quality and service [6][7] - **Management Advantage**: The company employs a group management model, ensuring efficient operation and high-quality service delivery across its facilities [7][8] - **Talent Team Advantage**: The workforce includes over 6,200 employees, with 25% holding senior technical titles and over 21% possessing master's or doctoral degrees [10][11] Financial Performance - In Q1 2020, the company experienced a loss despite an increase in outpatient and inpatient volumes, attributed to the short operational period of new medical services [10][11] - The company plans to raise up to 1 billion CNY through a private placement to enhance liquidity and repay bank loans, thereby improving its capital structure and risk resilience [12] Innovations and Collaborations - The company is advancing in the field of stem cell research and has partnered with international medical institutions to enhance service offerings [11][12] - The establishment of the Xi'an International Medical Rehabilitation Hospital, covering 425,000 square meters with 3,600 beds, aims to meet the growing demand for rehabilitation services [12] Community Engagement - The company is actively expanding its tiered medical network, collaborating with local healthcare institutions to improve service delivery and access for critical patients [12]

编号：2020-03 1 证券代码：000516 证券简称：国际医学 西安国际医学投资股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|----------------------------------------------|--------------------------------------------------------| | | | □特定对象调研 √分析师会议 | | | | □媒体采访 □业绩说明会 | | 投资者关系活动 | □ | 新闻发布会 □路演活动 | | 类别 | □现场参观 | | | | □ 其他 | | | 参与单位名称及 | | 中信建投张博、王在存、张永胜、刘京昭，工银瑞信赵蓓、丁 | | 人员姓名 | | 洋、李乾宁，国寿资产丁天宇，盘京资产曹姗姗，阳光资产谭 | | | | | | 时间 | 翔宇，鸿道投资王泳鑫 2020 年 7 月 10 | 日 14:00-15:00 | | 地点 | 电话会议 | | | | | | | 上市公司接待人 员姓名 | | 副总裁兼董事会秘书丁震、证 ...

证券代码：000516 证券简称：国际医学 编号：2020-10 1 西安国际医学投资股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|-----------|--------------------------------------------------------| | | | | | | | √特定对象调研 √分析师会议 | | | | □媒体采访 □业绩说明会 | | 投资者关系活动 | □ | 新闻发布会 □路演活动 | | 类别 | □现场参观 | | | | □ 其他 | | | 参与单位名称及 | | 1、分析师会议：信达证券杨松、周贤珮，人寿养老保险吴 | | 人员姓名 | | 颖、邹心勇、周介，中庚基金余思慧，天弘基金张秀磊、郭相 | | | | 博、刘萌萌，工银瑞信杨柯，永赢基金焦阳，信达澳银杨珂， | | | | 国寿养老赵垒，东方红孙梦瑶，泰康资产王晓锋，源乐晟马韵 | | | | 羽、欧阳明，平安基金乔海英、许汪洋，中银基金白洁，交银 | | | | 施罗德基金范煜、徐嘉辰，泰康资产金宏伟，金鹰基金欧阳 | | | | ...